89bio, Inc. reported earnings results for the first quarter ended March 31, 2023. For the first quarter, the company reported net loss was USD 28.84 million compared to USD 25.57 million a year ago. Basic loss per share from continuing operations was USD 0.54 compared to USD 1.26 a year ago.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
8.52 USD | +7.44% | -2.85% | -23.72% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-23.72% | 838M | |
+15.19% | 121B | |
+19.91% | 114B | |
+8.24% | 23.61B | |
-19.80% | 20.43B | |
-16.19% | 16.55B | |
-13.45% | 16.45B | |
-44.35% | 15.59B | |
+66.67% | 15.19B | |
+2.13% | 13.54B |
- Stock Market
- Equities
- ETNB Stock
- News 89bio, Inc.
- 89bio, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023